论文部分内容阅读
在急性非淋巴细胞白血病（ＡＮＬＬ）联合化疗的基础上加用了同源核糖核酸（ＲＮＡ），其结果显示：在联合化疗的基础上加用同源ＲＮＡ虽不能提高ＡＮＬＬ联合化疗的完全缓解率，但能减少复发率，并能改善患者的免疫功能，可作为ＡＮＬＬ联合化疗的辅助药物。
The use of homologous ribonucleic acid (RNA) on the basis of acute non-lymphocytic leukemia (ANLL) combined with chemotherapy showed that the addition of homologous RNA on the basis of combination chemotherapy did not improve the complete remission rate of ANLL combined with chemotherapy. , but can reduce the recurrence rate, and can improve the patient’s immune function, can be used as an adjuvant drug for ANLL combined with chemotherapy.